Maxwell is an early stage biotech company in lead optimization developing a broad spectrum virucide. Mimicking Human Cathelicidin Antimicrobial Peptide - humanity’s only cathelicidin antimicrobial peptide - Maxwell Biosciences is developing a completely new drug class proven to irreversibly destroy pandemic viruses like SARS-CoV-2, Hepatitis B, and Herpes Simplex Virus 1.
Privately Funded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):